Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to ELLIS, LEE M
Item TypeName
Academic Article Phase I study of recombinant human endostatin in patients with advanced solid tumors.
Academic Article Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.
Academic Article Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model.
Concept Angiogenesis Inhibitors
Academic Article Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
Academic Article Advances in the treatment of liver tumors.
Academic Article A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
Academic Article Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Academic Article Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
Academic Article Bevacizumab beyond progression: does this make sense?
Academic Article Predictive biomarkers for bevacizumab: are we there yet?
Academic Article The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
Academic Article Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice.
Academic Article Antiangiogenic therapy: more promise and, yet again, more questions.
Academic Article Bevacizumab.
Academic Article Vascular endothelial growth factor receptors: expression and function in solid tumors.
Academic Article Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
Academic Article Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer.
Academic Article Synopsis of angiogenesis inhibitors in oncology.
Academic Article Antiangiogenic therapy targeting factors that enhance endothelial cell survival.
Academic Article Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells.
Academic Article Biology of angiogenesis in tumors of the gastrointestinal tract.
Academic Article Promises and pitfalls of anti-angiogenic therapy in clinical trials.
Academic Article Can inhibition of angiogenic pathways increase the efficacy of intravenous 5-fluorouracil-based regimens?
Academic Article Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Academic Article Angiogenesis and its role in colorectal tumor and metastasis formation.
Academic Article Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
Academic Article Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
Academic Article VEGF-targeted therapy: mechanisms of anti-tumour activity.
Academic Article Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.
Academic Article Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Academic Article Antiangiogenic therapy--evolving view based on clinical trial results.
Academic Article Mechanisms of anti-angiogenic tyrosine kinase inhibition on wound healing--the obvious and not so obvious.
Academic Article Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
Academic Article ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.
Academic Article Preclinical data targeting vascular endothelial growth factor in colorectal cancer.
Academic Article Current overview of angiogenesis inhibitors.
Academic Article Cancer: The nuances of therapy.
Academic Article Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer.
Academic Article Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer.
Academic Article Antiangiogenic therapy in oncology: current status and future directions.
Search Criteria
  • Angiogenesis Inhibitors